At the beginning of the month, Lilly CEO David Ricks told Bloomberg that he expected the shortage to end very soon, adding that actually today or tomorrow we plan to exit that process. On a recent earnings call, Lilly announced that seven sites are expected to help alleviate the supply issues
"The medication might be degraded faster in one individual than in another," she says, which might also explain the different responses to GLP-1s
Traveling with Weight Loss Medication like Wegovy & Zepbound
Teva announces FDA approval and launch of generic Saxenda (liraglutide injection) first generic GLP-1 indicated for weight loss
Each morning, dump one bag into your blender, add your liquid base, scoop in your protein powder, and blend
In SUSTAIN 7, gastrointestinal side effects occurred at comparable rates across both medications